# Framework Agreement For Producer Cell Line For GMP Viral Vector Packaging

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS Blood & Transplant](/buyers/nhs-blood-and-transplant/contract-awards)
- Tender value: £100,000
- Published: 3 June 2020
- Planned start: 1 May 2021
- Planned end: 30 September 2023
- Stage: open_tender
- Procurement category: goods
- Notice ID: ddb492e1-255a-4c98-85fd-647c041c5232-362031
- OCID: ocds-b5fd17-8781e3bf-98bb-489d-8e81-af61c3421f67

## Description

NHSBT's Clinical Biotechnology Centre has a requirement for specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins\. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials\. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required

## Related contract awards

- [Media Monitoring Service & stakeholder Engagement Platform](/contracts/ocds-b5fd17-cd0d9254-7335-4fd0-893c-0253076b8c15): NHS Blood and Transplant
- [Computer Aided Facilities Management System](/contracts/ocds-b5fd17-abf1542f-53a3-4fa9-921c-5a092436c1d3): NHS Blood and Transplant
- [Contingent Labour - Multidisciplinary Temporary Healthcare](/contracts/ocds-b5fd17-6558bcb2-3d29-464a-8140-5767c4aac368): NHS Blood and Transplant

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/ddb492e1-255a-4c98-85fd-647c041c5232-362031)